$0.388
-0.005 (-1.17%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ENSC por análisis de gráficos similares
Alphio's ENSC stock price prediction model matches the current Ensysce Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.38 (-1.43%). The 1-week path is $0.38 (-1.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Ensysce Biosciences Inc?
Ensysce Biosciences Inc is a good buy right now due to its recent acquisition of Cy Biopharma and securing $77 million in financing, which has positively impacted its stock price, increasing by 44.83% to $0.52. Additionally, the stock has shown a 58.06% increase over the last 20 days, indicating strong momentum. However, the company has a high risk with a current debt to equity ratio of 0%, suggesting potential financial instability if revenues do not improve.
ENSC cerró en $0.39 el Tuesday, tras bajar -1.17%
Ensysce Biosciences Inc (ENSC) last closed at $0.3881, losing -1.17%. These facts feed the 1-day and 1-week ENSC price prediction above.
Factores de la previsión
Los factores de la previsión de Ensysce Biosciences Inc (ENSC) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ENSC, ordenadas por similitud.
Análisis de estacionalidad de ENSC
Historically the probability of a positive September return for ENSC is 0.00%. January offers the highest probability of a positive month at 42.62%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.